BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnston E, Emani C, Kochan A, Ghebrehawariat K, Tyburski J, Johnston M, Rabago D. Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro. J Exp Orthop 2020;7:97. [PMID: 33280075 DOI: 10.1186/s40634-020-00312-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nair A. Prolotherapy as an intervention for chronic, refractory musculoskeletal pain. Saudi J Anaesth 2021;15:463-5. [PMID: 34658744 DOI: 10.4103/sja.sja_374_21] [Reference Citation Analysis]
2 Johnston E, Emani C, Kochan A, Ghebrehawariat K, Tyburski J, Johnston M, Rabago D. Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro. J Exp Orthop 2020;7:100. [PMID: 33367968 DOI: 10.1186/s40634-020-00323-w] [Reference Citation Analysis]
3 Johnston E, Kou Y, Junge J, Chen L, Kochan A, Johnston M, Rabago D. Hypertonic Dextrose Stimulates Chondrogenic Cells to Deposit Collagen and Proliferate. Cartilage 2021;:19476035211014572. [PMID: 34109827 DOI: 10.1177/19476035211014572] [Reference Citation Analysis]